Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 2, Kidney Disease, Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07471802
What this trial is testing

Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)

Who this might be right for
Diabete Type 2Heart FailureKidney Disease, Chronic+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 150
Not applicableLooking for participantsNCT07309094
What this trial is testing

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

Who this might be right for
Chronic Kidney Disease stage3Chronic Kidney Disease stage4Chronic Kidney Disease Stage 1+3 more
Cardenal Herrera University 250
Large-scale testing (Phase 3)Ended earlyNCT00120328
What this trial is testing

To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Speedel Pharma Ltd. 2,364
Not applicableStudy completedNCT04445181
What this trial is testing

A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)

Who this might be right for
Chronic Kidney Disease in Type 2 Diabetes
Bayer 14,873
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Early research (Phase 1)Looking for participantsNCT07619157
What this trial is testing

ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type2 Diabetes MellitusChronic Kidney Disease
Ono Pharmaceutical Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT02251431
What this trial is testing

Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney DiseaseLeft Ventricular Diastolic Dysfunction
Baylor Research Institute 57
Post-approval studies (Phase 4)Study completedNCT02009514
What this trial is testing

Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients

Who this might be right for
End-Stage Kidney DiseaseType 2 Diabetes Mellitus
Tampere University Hospital 10
Not applicableStudy completedNCT05180604
What this trial is testing

The Application and Evaluation of eHealth Literacy (eHL) Concept

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney DiseasesCardiovascular Diseases
National Yang Ming Chiao Tung University 92
Not applicableActive Not RecruitingNCT05348733
What this trial is testing

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 4,613
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableLooking for participantsNCT06953180
What this trial is testing

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Who this might be right for
Cardiovascular Diseases (CVD)Type 2 DiabetesChronic Respiratory Diseases+2 more
Asfendiyarov Kazakh National Medical University 6,720
Post-approval studies (Phase 4)UnknownNCT06281899
What this trial is testing

Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Chronic Kidney DiseasesType 2 Diabetes Mellitus
Anemia Working Group Romania 200
Not applicableStudy completedNCT05585268
What this trial is testing

Electronic Decision Support for Deprescribing in Patients on Hemodialysis

Who this might be right for
End Stage Renal DiseaseHypertensionDiabete Type 2+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 195
Not applicableStudy completedNCT05577650
What this trial is testing

Prevalence of Chronic Kidney Disease in Tunisian Diabetics

Who this might be right for
Chronic Kidney DiseasesDiabetes MellitusDiabetes Type 2
Dacima Consulting 10,145
Large-scale testing (Phase 3)Study completedNCT03242252
What this trial is testing

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 3
Lexicon Pharmaceuticals 787
Early research (Phase 1)Study completedNCT05294458
What this trial is testing

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Who this might be right for
Non-alcoholic SteatohepatitisType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
AstraZeneca 10
Testing effectiveness (Phase 2)Study completedNCT01356849
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 149
Not applicableNot Yet RecruitingNCT07605390
What this trial is testing

RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 600
Testing effectiveness (Phase 2)Ended earlyNCT02525263
What this trial is testing

Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Prokidney 1
Next Page